Literature DB >> 16886674

The impact of chromatin organization of vitamin D target genes.

Carsten Carlberg1, Thomas W Dunlop.   

Abstract

The vitamin D receptor (VDR), the nuclear receptor for 1alpha,25-dihydroxyvitamin D3 (1alpha,25(OH)2D3), controls gene expression by binding discrete DNA sequences in promoter regions of target genes, referred to as 1alpha,25(OH)2D3 response elements (VDREs). Although these elements are well characterized in vitro, the function of VDREs in living cells in the context of chromatin is still largely unknown. To resolve this issue, 7 to 8 kB of the promoter regions of the primary 1alpha,25(OH)2D3 target genes CYP24, cyclin C and p21(Waf1/Cip1) were studied by chromatin immunoprecipitation (ChIP) assays using antibodies against acetylated histone H4 (to assess the global chromatin status) and various other components of VDR-dependent gene activation, such as VDR, retinoid X receptor (RXR), coactivator (CoA) and corepressor proteins. This approach identified three to four functional VDREs per gene promoter. In parallel, the extended analysis of the gene areas, of all six members of the insulin-like growth factor binding protein (IGFBP) family (i.e., 10 kB of promoter, introns, exons and 10 kB of the downstream region) were screened in silico for putative VDR-binding sites. Gel shift, reporter gene and ChIP assays identified, in total, ten functional VDREs in the genes IGFBP1, 3 and 5 and real-time PCR confirmed that these genes are primary VDR targets. Taken together, these results suggest that a reasonable proportion of all VDR target genes, if not all, are under the control of multiple VDREs. These results will have an impact on the development of therapeutic regimes for diseases, such as cancer, that use 1alpha,25(OH)2D3 and its analogs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886674

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Dynamic nature of transcriptional regulation of nuclear receptor target genes in the context of chromatin organization.

Authors:  Sami Väisänen; Juha Matilainen; Carsten Carlberg
Journal:  Dermatoendocrinol       Date:  2011-07-01

2.  Vitamin D and Mammographic Findings.

Authors:  J Riedel; L Straub; J Wissing; A Artmann; M Schmidmayr; M Kiechle; V R Seifert-Klauss
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-05       Impact factor: 2.915

3.  TaqI polymorphism of VDR gene contributes to breast cancer risk.

Authors:  Hua Wang; Wenjian Wang; Dongjie Yang; Shenming Wang
Journal:  Tumour Biol       Date:  2013-08-01

Review 4.  Vitamin D receptor signaling and pancreatic cancer cell EMT.

Authors:  Zhiwei Li; Junli Guo; Keping Xie; Shaojiang Zheng
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  The Vitamin D Receptor, Inflammatory Bowel Diseases, and Colon Cancer.

Authors:  Rong Lu; Shaoping Wu; Yinglin Xia; Jun Sun
Journal:  Curr Colorectal Cancer Rep       Date:  2012-03-01

Review 6.  Protective links between vitamin D, inflammatory bowel disease and colon cancer.

Authors:  Stacey Meeker; Audrey Seamons; Lillian Maggio-Price; Jisun Paik
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

7.  A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.

Authors:  Sreeram V Ramagopalan; Andreas Heger; Antonio J Berlanga; Narelle J Maugeri; Matthew R Lincoln; Amy Burrell; Lahiru Handunnetthi; Adam E Handel; Giulio Disanto; Sarah-Michelle Orton; Corey T Watson; Julia M Morahan; Gavin Giovannoni; Chris P Ponting; George C Ebers; Julian C Knight
Journal:  Genome Res       Date:  2010-08-24       Impact factor: 9.043

8.  LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.

Authors:  Sebastiano Battaglia; Ellen Karasik; Bryan Gillard; Jennifer Williams; Trisha Winchester; Michael T Moser; Dominic J Smiraglia; Barbara A Foster
Journal:  Clin Epigenetics       Date:  2017-08-11       Impact factor: 6.551

9.  Vitamin d: are we ready to supplement for breast cancer prevention and treatment?

Authors:  Katherine D Crew
Journal:  ISRN Oncol       Date:  2013-02-26

10.  Cell-Type Specific Determinants of NRAMP1 Expression in Professional Phagocytes.

Authors:  Mathieu F M Cellier
Journal:  Biology (Basel)       Date:  2013-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.